Nigel Trudgill

ORCID: 0000-0002-8040-8158
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Gastroesophageal reflux and treatments
  • Eosinophilic Esophagitis
  • Colorectal Cancer Screening and Detection
  • Inflammatory Bowel Disease
  • Helicobacter pylori-related gastroenterology studies
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Surgical Treatments
  • Microscopic Colitis
  • Child Nutrition and Feeding Issues
  • Dysphagia Assessment and Management
  • Gastrointestinal motility and disorders
  • COVID-19 Clinical Research Studies
  • Diverticular Disease and Complications
  • Gallbladder and Bile Duct Disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Clinical Nutrition and Gastroenterology
  • Gastrointestinal Tumor Research and Treatment
  • Pancreatitis Pathology and Treatment
  • Gastrointestinal disorders and treatments
  • Venous Thromboembolism Diagnosis and Management
  • Lung Cancer Diagnosis and Treatment

University of Birmingham
2011-2025

Sandwell & West Birmingham Hospitals NHS Trust
2016-2025

Sandwell General Hospital
2016-2025

Oxford Health NHS Foundation Trust
2025

University Hospitals Birmingham NHS Foundation Trust
2024

Queen Elizabeth Hospital
2024

NIHR Surgical Reconstruction and Microbiology Research Centre
2023

Medical Research Council
2021

University of Leicester
2021

University of Dundee
2021

These guidelines provide a practical and evidence-based resource for the management of patients with Barrett9s oesophagus related early neoplasia. The Appraisal Guidelines Research Evaluation (AGREE II) instrument was followed to methodological strategy guideline development. A systematic review literature performed English language articles published up until December 2012 in order address controversial issues including definition, screening diagnosis, surveillance, pathological grading...

10.1136/gutjnl-2013-305372 article EN Gut 2013-10-28

Upper gastrointestinal (UGI) cancer in the Western world usually presents at an advanced stage, when opportunities for curative therapy are limited. The failure to detect subtle, early-stage UGI endoscopy may contribute a poor prognosis. We undertook meta-analysis of studies endoscopic miss rates quantify how often diagnose earlier stage missed.A MEDLINE search was conducted identify relevant studies, and conducted. "Missed" defined as that had not been diagnosed by performed within 3 years...

10.1055/s-0034-1365524 article EN cc-by-nc-nd Endoscopy International Open 2014-05-07

This document represents the first position statement produced by British Society of Gastroenterology and Association Upper Gastrointestinal Surgeons Great Britain Ireland, setting out minimum expected standards in diagnostic upper gastrointestinal endoscopy. The need for this has arisen from recognition that while technical competence can be rapidly acquired, practice performance a high-quality examination is variable, with an unacceptably high rate failure to diagnose cancer at importance...

10.1136/gutjnl-2017-314109 article EN cc-by-nc Gut 2017-08-18

Oesophageal adenocarcinoma is the sixth most common cause of cancer death worldwide and Barrett's oesophagus biggest risk factor. We aimed to evaluate efficacy high-dose esomeprazole proton-pump inhibitor (PPI) aspirin for improving outcomes in patients with oesophagus.

10.1016/s0140-6736(18)31388-6 article EN cc-by The Lancet 2018-07-26

10.1038/ng.2408 article EN Nature Genetics 2012-09-09
Claire Palles Laura Chegwidden Xinzhong Li John M. Findlay Garry Farnham and 93 more Francesc Castro-Giner Maikel P. Peppelenbosch Michal Kováč Claire Adams Hans Prenen Sarah Briggs Rebecca Harrison S. Sanders David MacDonald Chris Haigh Art Tucker Sharon Love Manoj Nanji John de Caestecker David Ferry B J Rathbone Julie Hapeshi Hugh Barr Paul Moayyedi Peter J. Watson Barbara Zietek Neera Maroo Laura Gay Timothy J. Underwood Lisa Boulter Hugh McMurtry David Gabriel Monk Praful Patel Krish Ragunath David Al Dulaimi Iain Murray Konrad Koss Andrew Veitch Nigel Trudgill Chuka Nwokolo Björn Rembacken Paul Atherfold Elaine Green Yeng Ang Ernst J. Kuipers W H Chow Stuart Paterson Sudarshan Kadri Ian Beales Charles Grimley Paul D. Mullins Conrad Beckett Mark Farrant Andrew Dixon Sean G. Kelly Matthew E. Johnson Saj Wajed Anjan Dhar Elinor J. Sawyer Rebecca Roylance Lynn Onstad Marilie D. Gammon Douglas A. Corley Nicholas J. Shaheen Nigel C. Bird Laura J. Hardie Brian J. Reid Weimin Ye Geoffrey Liu Yvonne Romero Leslie Bernstein Anna H. Wu Alan G. Casson Rebecca C. Fitzgerald David C. Whiteman Harvey A. Risch David Levine Tom L. Vaughan Auke P. Verhaar Jan Van den Brande Eelke L.A. Toxopeus Manon C.W. Spaander Bas P. L. Wijnhoven Luc J. W. van der Laan Kausilia K. Krishnadath Cisca Wijmenga Gosia Trynka Ross McManus John V. Reynolds Jacintha O’Sullivan Padraic MacMathúna Sarah A. McGarrigle Dermot Kelleher Séverine Vermeire Isabelle Cleynen Raf Bisschops Ian Tomlinson Janusz Jankowski

Barrett's esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC). We found to be BE has been associated with single nucleotide polymorphisms (SNPs) on chromosome 6p21 (within HLA region) and 16q23, where closest protein-coding gene is FOXF1. Subsequently, Esophageal Adenocarcinoma Consortium (BEACON) identified loci for near CRTC1 BARX1, within 100 kb FOXP1. aimed identify further SNPs that increased validate previously reported associations.

10.1053/j.gastro.2014.10.041 article EN cc-by Gastroenterology 2014-11-05

These guidelines on oesophageal manometry and gastro-oesophageal reflux monitoring supersede those produced in 2006. Since 2006 there have been significant technological advances, particular, the development of high resolution (HRM) impedance monitoring. The were developed by a guideline group patients representatives all relevant professional groups using Appraisal Guidelines for Research Evaluation (AGREE II) tool. A systematic literature search was performed GRADE (Grading Recommendations...

10.1136/gutjnl-2018-318115 article EN cc-by-nc Gut 2019-07-31

Summary Background Data regarding incidence, prevalence and long‐term outcomes of inflammatory bowel diseases in the UK are limited or outdated. Aims To investigate incidence Crohn's disease ulcerative colitis risk colorectal cancer all‐cause mortality these diseases. Methods Inflammatory cases between 2000 2018 were identified from a national primary care database. was forecast until 2025. The association investigated using age/sex‐matched retrospective cohort studies. Hazard ratios...

10.1111/apt.15701 article EN cc-by-nc Alimentary Pharmacology & Therapeutics 2020-04-01

Over 2.5 million gastrointestinal endoscopic procedures are carried out in the United Kingdom (UK) every year. Procedures with local anaesthetic r sedation. Sedation is commonly used for endoscopy, but type and amount of sedation administered influenced by complexity nature procedure patient factors. The elective emergency endoscopy resources also have a significant impact on delivery In UK, vast majority sedated using benzodiazepines, or without opiates, whereas deeper propofol general...

10.1136/gutjnl-2023-330396 article EN cc-by-nc Gut 2023-10-10

Objective This national analysis aimed to calculate the diagnostic yield from gastroscopy for common symptoms, guiding improved resource utilisation. Design A cross-sectional study was conducted of gastroscopies between 1 March 2019 and 29 February 2020 using UK National Endoscopy Database. Mixed-effect logistic regression models were used, incorporating random (endoscopist) fixed (symptoms, age sex) effects on two dependent variables (endoscopic cancer; Barrett’s oesophagus (BO) diagnosis)....

10.1136/gutjnl-2024-332071 article EN Gut 2024-05-02

Studies of the relative frequency transient lower esophageal sphincter relaxations (TLESRs) in patients with gastroesophageal reflux disease and asymptomatic controls have revealed conflicting data. We therefore studied TLESRs mechanisms acid episodes age- sex-matched using standardized criteria.Ten symptomatic (four male, aged 50 [30-59] yr) 10 matched volunteers [32-59] were studied. Esophageal, sphincter, gastric manometric pH readings recorded for 1 h before after a 200-kcal, 150 ml...

10.1111/j.1572-0241.2001.04100.x article EN The American Journal of Gastroenterology 2001-09-01

Background —The incidence of adenocarcinoma the oesophagus and gastric cardia is increasing rapidly. Barrett’s major risk factor. Intestinal metaplasia at squamocolumnar junction in absence common but its relation to gastro-oesophageal reflux disease unclear. Aims —To study prevalence clinical, endoscopic, histological associations intestinal junction. Methods —Biopsy specimens were taken from 120 randomly selected patients undergoing routine diagnostic endoscopy. Eight biopsy specimens,...

10.1136/gut.41.5.585 article EN Gut 1997-11-01

Summary Aim: To examine the prevalence of gastro‐oesophageal reflux disease symptoms and potential risk factors among community subjects. Methods: A questionnaire was sent to 4000 subjects, stratified by age, gender ethnicity be representative local population. Gastro‐oesophageal were defined as at least weekly heartburn or acid regurgitation. Results: 2231 responded (59%), 691 refused participate seven incomplete. 1533 (41%) evaluable (637 male, mean age 51 years, range: 20–80). The 21%....

10.1111/j.1365-2036.2005.02426.x article EN Alimentary Pharmacology & Therapeutics 2005-03-24

BACKGROUND Aggregation of symptoms abdominal pain or bowel disturbance has been described in the families patients with irritable syndrome (IBS). This may be due to environmental factors, including learned responses a genetic contribution etiology IBS. OBJECTIVES To determine relative factors IBS by evaluating monozygotic (MZ) and dizygotic (DZ) twins. METHODS A total 4,480 unselected twin pairs identified from national volunteer register were asked complete validated questionnaire. was...

10.1111/j.1572-0241.2005.41700.x article EN The American Journal of Gastroenterology 2005-06-01

Relieving obstructive jaundice in inoperable pancreato-biliary cancers improves quality of life and permits chemotherapy. Percutaneous transhepatic cholangiography with drainage and/or stenting relieves but can be associated significant morbidity mortality. biliary (PTBD) malignant obstruction was therefore examined a national cohort to establish risk factors for poor outcomes.Retrospective study adult patients undergoing PTBD palliation cancer England between 2001 2014 identified from...

10.1136/bmjopen-2019-033576 article EN cc-by-nc BMJ Open 2020-01-01

The aim of this study was to develop a predictive model for overall survival after esophagectomy using pre/postoperative clinical data and machine learning.

10.1097/sla.0000000000004794 article EN cc-by Annals of Surgery 2021-02-27

Summary Background Patients with active inflammatory bowel disease (IBD) and mental illnesses experience worse IBD outcomes. Aim To describe the incidence of illnesses, including deliberate self‐harm, in patients. Methods A population‐based retrospective cohort study using IQVIA medical research data a primary care database covering whole UK, between January 1995 2021. patients all ages were matched 4:1 by demographics practice to unexposed controls. Following exclusion ill health at entry,...

10.1111/apt.17110 article EN Alimentary Pharmacology & Therapeutics 2022-06-30

Barrett’s oesophagus is the only known precursor to oesophageal adenocarcinoma, a cancer with very poor prognosis. The main risk factors for are history of gastro-oesophageal acid reflux symptoms and obesity. Men, smokers those family also at increased risk. Progression from occurs via an intermediate stage, as dysplasia. However, dysplasia early usually develop without any clinical signs, often in individuals whose well controlled by suppressant medications; therefore, endoscopic...

10.1136/gutjnl-2023-331557 article EN cc-by Gut 2024-03-29

Objective: A number of case reports describe multiple family members with gastroesophageal reflux disease and Barrett's esophagus. The wider importance familial factors in has not been established. Therefore, we have studied the prevalence symptoms medication use among relatives patients documented disease. Methods: postal questionnaire study first degree six groups matched patients. comprised 1) no dyspeptic symptoms; 2) a normal pH study; 3) symptoms, an abnormal study, lower esophageal...

10.1111/j.1572-0241.1999.01060.x article EN The American Journal of Gastroenterology 1999-05-01
Coming Soon ...